Literature DB >> 4092935

Methylation of plasmacytoma c-myc genes.

W Dunnick, J Baumgartner, L Fradkin, C Schultz, P Szurek.   

Abstract

The chromosomal translocation associated with many tumors of immunoglobulin-producing cells frequently results in the joining of the immunoglobulin heavy-chain locus and the c-myc oncogene. This translocation of c-myc has profound structural and functional consequences for the oncogene, including loss of the 5' end of the gene and transcriptional deregulation. We report in this communication that translocation results in a new methylation pattern of c-myc. In normal kidney and liver tissue, the c-myc gene is methylated at its 3' end. The translocated gene in plasmacytoma DNA is extensively demethylated. On the other hand, the nonrearranged c-myc gene in plasmacytoma DNA (which is transcriptionally silent) is extensively methylated. In addition, we confirm the nucleotide sequence (with 19 discrepancies out of 1400 bp) 5' to the murine c-myc gene, as reported by Corcoran et al. [Cell 40 (1985) 71-79].

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092935     DOI: 10.1016/0378-1119(85)90325-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter.

Authors:  E Kakkis; M Mercola; K Calame
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

2.  Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors.

Authors:  S E Mango; G D Schuler; M E Steele; M D Cole
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

3.  Negative autoregulation of c-myc transcription.

Authors:  L J Penn; M W Brooks; E M Laufer; H Land
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

4.  Patterns of methylation of the c-myc gene in human colorectal cancer progression.

Authors:  R M Sharrard; J A Royds; S Rogers; A J Shorthouse
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.